Niektóre treści mogą być tłumaczone maszynowo. Jeśli zauważysz błędy, skontaktuj się z nami
tutaj.
Wielojęzyczna baza danych jest na wczesnym etapie beta - zgłoś wszelkie zauważone problemy.
Źródło danych:
2023.
Strona zaktualizowana:
2025-06-04
W Indiach terapia zastępcza nikotynowa (NRT) jest dozwolona, a produkty NRT można legalnie używać, sprzedawać i kupować w sklepach ogólnodostępnych. Produkty te są regulowane jako leki. Rząd zapewnia pełne finansowanie kosztów NRT, ponieważ znajduje się ona na liście podstawowych leków kraju. W 2023 roku wartość rynku NRT w Indiach wyniosła 33,09 mln USD.
Promocja produktu
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | 19.5 million € | 1A |
| 2023 | USD 33.09 million in 2023 | 1B |
Źródła:
- Consumer Health: Euromonitor from trade sources/national statistics. Date Exported: 8/9/2019. (c) Euromonitor International 2019
- Grand View Research. India Nicotine Replacement Therapy Market. Available at: https://www.grandviewresearch.com/industry-analysis/india-nicotine-replacement-therapy-market-report. Accessed: 9 May 2025.
0.3 €
2
2019
Źródła:
- Grand View Research. India Nicotine Replacement Therapy Market. Available at: https://www.grandviewresearch.com/industry-analysis/india-nicotine-replacement-therapy-market-report. Accessed: 9 May 2025.
- Consumer Health: Euromonitor from trade sources/national statistics. Date Exported: 8/9/2019. (c) Euromonitor International 2019
Regulacje
Źródła:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
Dostępność
Tak
1
2022
Tak
1
2022
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | Tak | 1A |
| 2022 | Tak | 1B |
Źródła:
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
Tak
2
2019
| Year | Value | Reference/Comment |
|---|---|---|
| 2019 | many general shops without a prescription | 1A |
| 2022 | General stores | 1B |
Źródła:
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
Źródła:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
- WHO Report on the Global Tobacco Epidemic 2019. https://www.who.int/tobacco/global_report/en/ (2019).
Formalne wsparcie
Tak NRT is on the country's essential drugs list.
1
A
2022
Źródła:
- WHO report on the global tobacco epidemic, 2023. Available at: https://cdn.who.int/media/docs/default-source/country-profiles/tobacco/gtcr-2023/tobacco-2023-ind.pdf?sfvrsn=4d7d5aa2_3&download=true. Accessed: 6 May 2025.
Komentarze:
- NRT cost is fully covered by the government.
The GSTHR database is updated regularly by our team.
However, please be aware that the information we provide does not constitute legal advice.
We cannot guarantee that the information is up to date or accurate, as the regulatory status of different product
categories can change at short notice and with little publicity.
If you wish to check the legal status of use or possession of any safer nicotine product in a specific country or region,
you should verify the information independently.
If you have reason to think that the information supplied on the GSTHR is inaccurate, please contact us with details
and any references and we will rectify any errors.